EIF2AK2 antibody (C-Term)
Quick Overview for EIF2AK2 antibody (C-Term) (ABIN6735902)
Target
See all EIF2AK2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human EIF2AK2
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human EIF2AK2 (P19525, NP_002750). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey (100%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, IHC-P, WB (0.12 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))
-
Alternative Name
- EIF2AK2 / PKR
-
Background
-
Name/Gene ID: EIF2AK2
Subfamily: Translational Control Kinase
Family: Protein Kinase
Synonyms: EIF2AK2, p1/eIF-2A protein kinase, p68 kinase, PRKR, EIF-2A protein kinase 2, p68, Protein kinase RNA-activated, Tik -
Gene ID
- 5610
-
NCBI Accession
- NP_002750
-
UniProt
- P19525
-
Pathways
- DNA Damage Repair, ER-Nucleus Signaling, Hepatitis C
Target
-